Intangibles and the market value of biopharmaceutical startups
R Morales, F Radoniqi - The Journal of Business Inquiry, 2018 - journals.uvu.edu
This paper investigates the relationship between various measures of intangible capital and
the market valuation of young biopharmaceutical firms. We employ a non-linear model to
measure the impact of R&D, patents, alliances, organizational capital, and mergers on the
value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the
exception of mergers, our measures of intangible capital have positive and significant effects
on market values; the impact of R&D declines as firms mature; and the omission of either …
the market valuation of young biopharmaceutical firms. We employ a non-linear model to
measure the impact of R&D, patents, alliances, organizational capital, and mergers on the
value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the
exception of mergers, our measures of intangible capital have positive and significant effects
on market values; the impact of R&D declines as firms mature; and the omission of either …
Intangibles and the market value of Biopharmaceutical startups
RMM Valera, F Radoniqi - The Journal of Business Inquiry, 2018 - pure.udem.edu.mx
This paper investigates the relationship between various measures of intangible capital and
the market valuation of young biopharmaceutical firms. We employ a non-linear model to
measure the impact of R&D, patents, alliances, organizational capital, and mergers on the
value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the
exception of mergers, our measures of intangible capital have positive and significant effects
on market values; the impact of R&D declines as firms mature; and the omission of either …
the market valuation of young biopharmaceutical firms. We employ a non-linear model to
measure the impact of R&D, patents, alliances, organizational capital, and mergers on the
value of 349 newly-incorporated firms between 1980 and 2006. We find that, with the
exception of mergers, our measures of intangible capital have positive and significant effects
on market values; the impact of R&D declines as firms mature; and the omission of either …
以上显示的是最相近的搜索结果。 查看全部搜索结果